COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, AND METHOD FOR MODULATING ACTIVITY OF A GABAA RECEIVER.

• 收藏
• 分享

专利权人:

ASTRAZENECA AB.

发明人:

HUI-FANG CHANG,MARC CHAPDELAINE,BRUCE THOMAS DEMBOFSKY,KEITH JOHN HERZOG,CAREY HORCHLER,RICHARD JON SCHMIESING

申请号：

BRPI0813379

公开号：

BRPI0813379A2

申请日:

2008.06.18

申请国别(地区):

BR

年份:

2014

代理人:

摘要：

This invention relates to novel compounds having the structural formula I below: and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions and methods of use thereof, wherein R1, R2, R3, R4, R5, and R6 are defined in the specification. These novel compounds provide a treatment or prophylaxis of anxiety disorders, schizophrenia, cognitive disorders, and/or mood disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/